Advisors Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.17M Buy
14,579
+228
+2% +$124K 0.12% 230
2025
Q4
$8.32M Sell
14,351
-3,230
-18% -$1.83M 0.14% 179
2025
Q3
$8.53M Sell
17,581
-1,871
-10% -$871K 0.14% 167
2025
Q2
$7.89M Sell
19,452
-1,579
-8% -$660K 0.14% 173
2025
Q1
$10.5M Buy
21,031
+419
+2% +$227K 0.2% 112
2024
Q4
$10.7M Sell
20,612
-1,091
-5% -$600K 0.2% 109
2024
Q3
$13.4M Buy
21,703
+1,179
+6% +$698K 0.25% 79
2024
Q2
$11.3M Buy
20,524
+236
+1% +$135K 0.22% 88
2024
Q1
$11.8M Buy
20,288
+1,319
+7% +$740K 0.23% 92
2023
Q4
$10.1M Sell
18,969
-1,987
-9% -$962K 0.21% 111
2023
Q3
$10.6M Sell
20,956
-155
-0.7% -$82.6K 0.23% 87
2023
Q2
$11M Sell
21,111
-3,312
-14% -$1.79M 0.23% 91
2023
Q1
$14.1M Sell
24,423
-4,866
-17% -$2.74M 0.29% 61
2022
Q4
$16.1M Sell
29,289
-6,926
-19% -$3.67M 0.33% 54
2022
Q3
$18.4M Sell
36,215
-3,700
-9% -$2.07M 0.39% 47
2022
Q2
$21.7M Sell
39,915
-3,432
-8% -$1.89M 0.41% 42
2022
Q1
$25.6M Sell
43,347
-870
-2% -$500K 0.39% 44
2021
Q4
$29.5M Sell
44,217
-152
-0.3% -$94.9K 0.42% 36
2021
Q3
$25.3M Sell
44,369
-7,438
-14% -$4.08M 0.39% 37
2021
Q2
$26.1M Sell
51,807
-2,800
-5% -$1.32M 0.39% 39
2021
Q1
$24.9M Sell
54,607
-8,039
-13% -$3.84M 0.39% 37
2020
Q4
$29.2M Sell
62,646
-4,406
-7% -$2.07M 0.48% 30
2020
Q3
$29.6M Sell
67,052
-224
-0.3% -$92.5K 0.55% 28
2020
Q2
$24.4M Buy
67,276
+2,055
+3% +$689K 0.47% 30
2020
Q1
$18.5M Sell
65,221
-4,204
-6% -$1.33M 0.44% 34
2019
Q4
$22.6M Sell
69,425
-4,753
-6% -$1.44M 0.4% 40
2019
Q3
$21.6M Sell
74,178
-8,334
-10% -$2.39M 0.4% 44
2019
Q2
$24.2M Sell
82,512
-4,015
-5% -$1.11M 0.44% 36
2019
Q1
$23.7M Sell
86,527
-6,235
-7% -$1.55M 0.42% 40
2018
Q4
$20.8M Sell
92,762
-5,514
-6% -$1.29M 0.42% 44
2018
Q3
$24M Buy
98,276
+4,463
+5% +$1.03M 0.39% 42
2018
Q2
$19.4M Buy
93,813
+9,832
+12% +$2.09M 0.33% 61
2018
Q1
$17.5M Buy
83,981
+7,563
+10% +$1.59M 0.29% 78
2017
Q4
$14.5M Buy
76,418
+4,367
+6% +$837K 0.24% 104
2017
Q3
$13.6M Buy
72,051
+7,717
+12% +$1.4M 0.23% 104
2017
Q2
$11.2M Sell
64,334
-1,974
-3% -$332K 0.19% 131
2017
Q1
$10.2M Buy
66,308
+735
+1% +$112K 0.17% 156
2016
Q4
$9.25M Buy
65,573
+4,978
+8% +$734K 0.15% 180
2016
Q3
$9.64M Sell
60,595
-1,336
-2% -$206K 0.16% 183
2016
Q2
$9.15M Buy
61,931
+6,443
+12% +$951K 0.15% 197
2016
Q1
$7.86M Sell
55,488
-10,579
-16% -$1.42M 0.13% 231
2015
Q4
$9.37M Buy
66,067
+865
+1% +$115K 0.15% 196
2015
Q3
$7.97M Buy
65,202
+6,477
+11% +$844K 0.13% 228
2015
Q2
$7.62M Buy
58,725
+5,667
+11% +$739K 0.1% 264
2015
Q1
$7.13M Sell
53,058
-7,889
-13% -$1.02M 0.09% 271
2014
Q4
$7.64M Sell
60,947
-889
-1% -$108K 0.1% 251
2014
Q3
$7.53M Buy
61,836
+1,809
+3% +$220K 0.1% 247
2014
Q2
$7.08M Buy
60,027
+7,223
+14% +$850K 0.1% 253
2014
Q1
$6.35M Buy
52,804
+14,470
+38% +$1.72M 0.1% 265
2013
Q4
$4.27M Buy
38,334
+15,523
+68% +$1.54M 0.07% 349
2013
Q3
$2.1M Buy
22,811
+3,180
+16% +$288K 0.04% 472
2013
Q2
$1.66M Buy
+19,631
New +$1.63M 0.03% 507

Other funds holding TMO

Advisors Asset Management's TMO Position: Q1 2026 in Review

Advisors Asset Management increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, buying an estimated $124K and bringing the position to 14,579 shares worth $7.17M. The position accounts for 0.12% of the portfolio, ranked #230.

Advisors Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.6M in Q3 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Advisors Asset Management held 14,579 shares of Thermo Fisher Scientific worth $7.17M as of Q1 2026.
  • Advisors Asset Management bought 228 Thermo Fisher Scientific shares in Q1 2026, an estimated $124K.
  • Thermo Fisher Scientific made up 0.12% of Advisors Asset Management's portfolio in Q1 2026, its #230 holding.
  • Advisors Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Advisors Asset Management's Thermo Fisher Scientific position peaked at $29.6M in Q3 2020.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.